xemilofiban has been researched along with Blood Clot in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (57.14) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, CS; Cines, DB | 1 |
| Broschat, K; Haas, NF; Keller, BT; King, LW; Nicholson, NS; Panzer-Knodle, SG; Salyers, AK; Szalony, JA; Taite, BB; Zablocki, JA | 1 |
| Badimon, JJ; Badimon, L; Baron, DA; Chesebro, JH; Feigen, LP; Fuster, V; Meyer, B | 1 |
| Anders, RJ; Broderick, TM; Ferguson, JJ; Hantsbarger, G; Higby, NA; Kereiakes, DJ; Kleiman, N; Martin, LH; McDonald, S; Runyon, JP | 1 |
| Feigen, LP; Frederick, LG; King, LW; Nicholson, NS; Salyers, AK; Suleymanov, OD; Szalony, JA; Taite, BB | 1 |
| Davis, CJ; Lowry, DR; McKenzie, ME; Nair, GV; Serebruany, VL | 1 |
3 review(s) available for xemilofiban and Blood Clot
| Article | Year |
|---|---|
Platelet glycoprotein IIb/IIIa inhibitors and thrombocytopenia: possible link between platelet activation, autoimmunity and thrombosis.
Topics: Abciximab; Alanine; Antibodies, Monoclonal; Autoimmunity; Benzamidines; Humans; Immunoglobulin Fab Fragments; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Purpura, Thrombocytopenic, Idiopathic; Pyrrolidines; Thrombocytopenia; Thrombosis | 2002 |
Xemilofiban: SC 54684A, xemlofiban.
Topics: Angina Pectoris; Animals; Benzamidines; Cardiovascular Diseases; Dose-Response Relationship, Drug; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prodrugs; Thrombosis | 2003 |
Aspirin in patients with coronary artery disease: is it simply irresistible?
Topics: Abciximab; Antibodies, Monoclonal; Aspirin; Benzamidines; Clinical Trials as Topic; Clopidogrel; Coronary Disease; Cyclooxygenase Inhibitors; Diabetes Complications; Dipyridamole; Double-Blind Method; Drug Resistance; Drug Therapy, Combination; Endothelium, Vascular; Fibrinolytic Agents; Humans; Immunoglobulin Fab Fragments; Oximes; Piperidines; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prospective Studies; Randomized Controlled Trials as Topic; Stroke; Thrombosis; Thromboxane-A Synthase; Ticlopidine; Vasodilator Agents | 2001 |
1 trial(s) available for xemilofiban and Blood Clot
| Article | Year |
|---|---|
Sustained platelet glycoprotein IIb/IIIa blockade with oral xemilofiban in 170 patients after coronary stent deployment.
Topics: Abciximab; Administration, Oral; Aged; Antibodies, Monoclonal; Aspirin; Benzamidines; Coronary Disease; Dose-Response Relationship, Drug; Female; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Single-Blind Method; Stents; Thrombosis; Ticlopidine | 1997 |
3 other study(ies) available for xemilofiban and Blood Clot
| Article | Year |
|---|---|
SC-54684A: an orally active inhibitor of platelet aggregation.
Topics: Administration, Oral; Animals; Benzamides; Benzamidines; Biological Availability; Carbon Radioisotopes; Dogs; Fibrinogen; Humans; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Protein Binding; Sensitivity and Specificity; Thrombosis | 1995 |
Thrombosis triggered by severe arterial lesions is inhibited by oral administration of a glycoprotein IIb/IIIa antagonist.
Topics: Administration, Oral; Animals; Benzamidines; Blood Flow Velocity; Carotid Arteries; Carotid Artery Injuries; Dogs; Microscopy, Electron, Scanning; Perfusion; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombosis | 1997 |
Protective effect of oral xemilofiban in arterial thrombosis in dogs: increased activity in combination with aspirin.
Topics: Administration, Oral; Animals; Arterial Occlusive Diseases; Aspirin; Benzamidines; Binding Sites; Dogs; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Electric Stimulation; Female; Male; Platelet Aggregation Inhibitors; Templates, Genetic; Thrombosis | 1998 |